載入...
Predicting pathologic response to neoadjuvant chemoradiation in resectable stage III non-small cell lung cancer patients using computed tomography radiomic features
OBJECTIVE: The use of a neoadjuvant chemoradiation followed by surgery in patients with stage IIIA NSCLC is controversial and the benefit of surgery is limited. There are currently no clinically validated biomarkers to select patients for such an approach. In this study we evaluate computed tomograp...
Na minha lista:
| 發表在: | Lung Cancer |
|---|---|
| Main Authors: | , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
2019
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6711393/ https://ncbi.nlm.nih.gov/pubmed/31446979 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.lungcan.2019.06.020 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|